| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McArdle Laboratory for Cancer Research, University of Wisconsin Center for Health Sciences, Madison, Wisconsin 53706
Vinyl carbamate was much more active (10 to 50 times) than ethyl carbamate for the initiation of skin tumors and for the induction of lung adenomas in mice. Vinyl carbamate was also mutagenic to Salmonella typhimurium TA 1535 and TA 100 in the presence of reduced nicotinamide adenine dinucleotide phosphate-fortified rat or mouse liver mitochondrial supernatant fractions. This mutagenic activity was inhibited strongly by cytochrome P-450 inhibitors. No mutagenic activity was observed for vinyl carbamate in the absence of added liver preparations or for ethyl carbamate in the presence or absence of liver fractions.
Extensive tests with sensitive methods failed to detect vinyl carbamate as a metabolite of ethyl carbamate in the mouse in vivo. However, on administration of [ethyl-1-14C;1,2-3H]ethyl carbamate to adult mice the 3H/14C ratios of the hepatic DNA-, rRNA-, and protein-adducts were similar to each other and much lower than the ratio of the administered ethyl carbamate. These data are consistent with the presence of desaturated and/or oxidized ethyl groups in the macromolecular adducts. The qualitatively similar, but much stronger, carcinogenic activity of vinyl carbamate as compared to that of ethyl carbamate suggests that the metabolic pathways of these two carbamates may converge in the formation of similar or identical electrophilic reactants that bind covalently to macromolecules in vivo and initiate carcinogenesis.
1 In honor of the 70th birthday of Dr. Harold P. Rusch, M. D., founder and long-time Director of the McArdle Laboratory for Cancer Research and creator of its productive research atmosphere.
This work was supported by Grants CA-07175, CA-15785, CA-22484, and CA-09135 from the National Cancer Institute, USPHS.
2 To whom requests for reprints should be addressed.
Received 6/26/78. Accepted 8/14/78.
This article has been cited by other articles:
![]() |
M. B. Sporn A New Tumor Suppressor Gene, Selective for Lung Cancer J Natl Cancer Inst, November 21, 2007; 99(22): 1654 - 1655. [Full Text] [PDF] |
||||
![]() |
L. G. Hernandez and P.-G. Forkert Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1 (Big Blue(R) x A/J) transgenic mice Carcinogenesis, August 1, 2007; 28(8): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Forkert, M. Kaufmann, G. Black, R. Bowers, H. Chen, K. Collins, A. Sharma, and G. Jones Oxidation of Vinyl Carbamate and Formation of 1,N6-Ethenodeoxyadenosine in Murine Lung Drug Metab. Dispos., May 1, 2007; 35(5): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liby, D. B. Royce, C. R. Williams, R. Risingsong, M. M. Yore, T. Honda, G. W. Gribble, E. Dmitrovsky, T. A. Sporn, and M. B. Sporn The Synthetic Triterpenoids CDDO-Methyl Ester and CDDO-Ethyl Amide Prevent Lung Cancer Induced by Vinyl Carbamate in A/J Mice Cancer Res., March 15, 2007; 67(6): 2414 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Ghanayem Inhibition of Urethane-Induced Carcinogenicity in Cyp2e1-/- in Comparison to Cyp2e1+/+ Mice Toxicol. Sci., February 1, 2007; 95(2): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hoffler and B. I. Ghanayem INCREASED BIOACCUMULATION OF URETHANE IN CYP2E1-/- VERSUS CYP2E1+/+ MICE Drug Metab. Dispos., August 1, 2005; 33(8): 1144 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hoffler, H. A. El-Masri, and B. I. Ghanayem Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism: Comparative Studies Using CYP2E1-Null and Wild-Type Mice J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 557 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, G. E. Dinse, J. F. Foley, J. F. Hardisty, and R. R. Maronpot Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice Toxicol Pathol, August 1, 2002; 30(5): 599 - 605. [Abstract] [PDF] |
||||
![]() |
P.-G. Forkert, R. P. Lee, and K. Reid Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes Drug Metab. Dispos., March 1, 2001; 29(3): 258 - 263. [Abstract] [Full Text] |
||||
![]() |
A. P. Titis and P.-G. Forkert Strain-Related Differences in Bioactivation of Vinyl Carbamate and Formation of DNA Adducts in Lungs of A/J, CD-1, and C57BL/6 Mice Toxicol. Sci., January 1, 2001; 59(1): 82 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Lee and P.-G. Forkert Inactivation of Cytochrome P-450 (CYP2E1) and Carboxylesterase (Hydrolase A) Enzymes by Vinyl Carbamate in Murine Pulmonary Microsomes Drug Metab. Dispos., February 1, 1999; 27(2): 233 - 239. [Abstract] [Full Text] |
||||
![]() |
M. J. Coon, A. D. N. Vaz, D. F. McGinnity, and H.-M. Peng Multiple Activated Oxygen Species in P450 Catalysis. Contributions to Specificity in Drug Metabolism Drug Metab. Dispos., December 1, 1998; 26(12): 1190 - 1193. [Abstract] [Full Text] |
||||
![]() |
M. Saparbaev and J. Laval 3,N4-ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase PNAS, July 21, 1998; 95(15): 8508 - 8513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. N. Vaz, D. F. McGinnity, and M. J. Coon Epoxidation of olefins by cytochrome P450: Evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant PNAS, March 31, 1998; 95(7): 3555 - 3560. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Lee, A. Parkinson, and P.-G. Forkert Isozyme-Selective Metabolism of Ethyl Carbamate by Cytochrome P450 (CYP2E1) and Carboxylesterase (Hydrolase A) Enzymes in Murine Liver Microsomes Drug Metab. Dispos., January 1, 1998; 26(1): 60 - 65. [Abstract] [Full Text] |
||||
![]() |
R. W. Benson and F. A. Beland Modulation of Urethane (Ethyl Carbamate) Carcinogenicity by Ethyl Alcohol: A Review International Journal of Toxicology, November 1, 1997; 16(6): 521 - 544. [Abstract] [PDF] |
||||
![]() |
J. A. Wright, A. M. Marsden, J. M. Willets, and T. C. Orton Hepatocarcinogenic Effect of Vinyl Carbamate in the C57B1/10J Strain Mouse Toxicol Pathol, April 1, 1991; 19(3): 258 - 265. [Abstract] [PDF] |
||||
![]() |
S. Parodi, M. Taningher, P. Boero, and L. Santi Quantitative Correlation with Carcinogenic Potency of Different Short Term Tests Toxicol Pathol, April 1, 1984; 12(3): 247 - 255. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |